ProQR Therapeutics BV Capital Reinvestment Ratio
ProQR Therapeutics BV capital reinvestment ratio. ProQR Therapeutics BV (PRQR) has a Capital Reinvestment Ratio of 0.00x as of March 2023, meaning it reinvests 0% of its operating cash flow ($44.73 Million) in capital expenditures ($136.00K). Check how aggressively does ProQR Therapeutics BV reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of ProQR Therapeutics BV (2023–2023)
Capital reinvestment ratio of ProQR Therapeutics BV from 2023 to 2023. This chart tracks ProQR Therapeutics BV's Capital Reinvestment Ratio across 1 annual periods. Also explore PRQR net assets growth trend to track the company's year-over-year net asset growth rate.
ProQR Therapeutics BV Capital Reinvestment Ratio by Year (2023–2023)
ProQR Therapeutics BV capital reinvestment ratio by year from 2023 to 2023. For the full cash flow conversion analysis, see ProQR Therapeutics BV cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.06x | $21.55 Million | $1.37 Million | — |